Multiple Cycles of Granulocyte Colony-Stimulating Factor Increase Survival Times of Patients With Decompensated Cirrhosis in a Randomized Trial
- 1 February 2021
- journal article
- research article
- Published by Elsevier in Clinical Gastroenterology and Hepatology
- Vol. 19 (2) , 375-383.e5
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Efficacy of Granulocyte Colony-Stimulating Factor and N-Acetylcysteine Therapies in Patients With Severe Alcoholic HepatitisClinical Gastroenterology and Hepatology, 2018
- Outcomes after multiple courses of granulocyte colony‐stimulating factor and growth hormone in decompensated cirrhosis: A randomized trialHepatology, 2018
- Early cirrhosis and a preserved bone marrow niche favour regenerative response to growth factors in decompensated cirrhosisLiver International, 2018
- Therapeutic implications of granulocyte colony stimulating factor in patients with acute-on-chronic liver failure: increased survival and containment of liver damageHepatology International, 2017
- Combination of Granulocyte Colony-Stimulating Factor and Erythropoietin Improves Outcomes of Patients With Decompensated CirrhosisGastroenterology, 2015
- Granulocyte Colony-Stimulating Factor in Severe Alcoholic Hepatitis: A Randomized Pilot StudyAmerican Journal of Gastroenterology, 2014
- Multiple courses of G-CSF in patients with decompensated cirrhosis: consistent mobilization of immature cells expressing hepatocyte markers and exploratory clinical evaluationHepatology International, 2013
- Granulocyte Colony–Stimulating Factor Mobilizes CD34+ Cells and Improves Survival of Patients With Acute-on-Chronic Liver FailureGastroenterology, 2012
- Bone marrow-derived stem cells in liver repair: 10 years down the lineLiver Transplantation, 2010
- Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studiesJournal of Hepatology, 2006